Literature DB >> 1147456

Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy.

A de Torrente, M M Popovtzer, S J Guggenheim, R W Schrier.   

Abstract

A patient suffered from acute glomerulonephritis with modest renal impairment and life-threatening pulmonary hemorrhage. The pulmonary hemorrhage caused severe hypoxia that necessitated artificial ventilation. As a last resort, 1 g/day of methylprednisolone was administered intravenously. Rapid cessation of pulmonary hemorrhage ensued with clearing of the lungs fields. We suggest that large doses of glucocorticosteroids should be administered to patients with life-threatening pulmonary hemorrhage before considering bilateral nephrectomy, especially if the renal function is still adequate. Bilateral nephrectomy is an irreversible approach and, as with massive doses of steroids, has yet to be proved to be a consistently effective mode of therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1147456     DOI: 10.7326/0003-4819-83-2-218

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Acute noncrescentic poststreptococcal glomerulonephritis presenting with pulmonary hemorrhage.

Authors:  N Gilboa; S McIntire; L Hopp; D Ellis
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 2.  Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan.

Authors:  Kouichi Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2008-04-08       Impact factor: 2.801

3.  A Pediatric Case of Diffuse Alveolar Hemorrhage Secondary to Poststreptococcal Glomerulonephritis.

Authors:  Alison Markland; Gregory Hansen; Anke Banks; Rajni Chibbar; Darryl Adamko
Journal:  Case Rep Crit Care       Date:  2017-12-20

4.  A case of post-streptococcal glomerulonephritis with diffuse alveolar hemorrhage.

Authors:  Hye Young Sung; Chang Hoon Lim; Mi Jung Shin; Byung Soo Kim; Young Ok Kim; Ho Chul Song; Suk Young Kim; Euy Jin Choi; Yoon Sik Chang; Byung Kee Bang
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.